Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-27 @ 2:42 AM
Study NCT ID:
NCT01228357
Status:
UNKNOWN
Last Update Posted:
2015-12-31
First Post:
2010-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predict Antidepressant Responsiveness Using Pharmacogenomics
Sponsor:
Samsung Medical Center
Organization:
Study Overview
Official Title:
Predict Antidepressant Responsiveness Using Pharmacogenomics
Status:
UNKNOWN
Status Verified Date:
2015-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether genetic information associated with individual depressive symptoms.
Detailed Description:
The primary hypothesis is that the variations of the candidate genes are associated with individual symptoms in patients with depression.
The Second hypothesis is that patients with the associated genetic variation suffer longer from the associated symptom than the patients without the associated genetic variation.
The Second hypothesis is that patients with the associated genetic variation suffer longer from the associated symptom than the patients without the associated genetic variation.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: